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Chronic liver disease (CLD) features constant parenchymal injury and repair together
with an increasing hepatic impairment, finally leading to fibrosis and cirrhosis and a
heightened risk of hepatocellular carcinoma (HCC). Closely related to the rise in obesity,
the worldwide prevalence of nonalcoholic fatty liver disease, the most common form of
CLD, has reached an epidemic dimension and is estimated to afflict up to 46% of the
general population, including more than one out of three U.S. citizens. Up to now there is
no effective drug treatment available, which is why recommendations encompass both
exercise programs and changes in dietary habits. Exercise is well-known for unleashing
potent anti-inflammatory effects, which can principally counteract liver inflammation
and chronic low-grade inflammation. This review article summarizes the underlying
mechanisms responsible for the exercise-mediated anti-inflammatory effects, illustrates
the application in animal models as well as in humans, and highlights the therapeutic
value when possible. Based on the available results there is no doubt that exercise can
even be beneficial in an advanced stage of liver disease and it is the goal of this review
article to provide evidence for the therapeutic impact on fibrosis, cirrhosis, and HCC
and to assess whether exercise might be of value as adjuvant therapy in the treatment
of CLD. In principle, all exercise programs carried out in these high-risk patients should
be guided and observed by qualified healthcare professionals to guarantee the patients’
safety. Nevertheless, it is also necessary to additionally determine the optimal amount
and intensity of exercise to maximize its value, which is why further studies are essential.
Keywords: exercise, liver fibrosis, regulatory T cells, cytokines, adaptive immune system, cortisol, monocytes,
inflammation
Abbreviations: α-SMA, α-smooth muscle actin; ACTH, adrenocorticotropin hormone; ALT, alanine aminotransferase;
AMP, adenosine monophosphate; AMPK, AMP-activated protein kinase; ANGPTL2, angiopoietin-like protein 2; APC,
antigen-presenting cell; AST, aspartate aminotransferase; AVP, arginine vasopressin; CCL2, CC-chemokine ligand 2; CNCDs,
chronic non-communicable disease(s); CLD, chronic liver disease; CRF, corticotropin releasing factor; CRP, C-reactive
protein; CXCL5, CXC-chemokine ligand 5; DEN, diethylnitrosamine; FFA, free fatty acid; Foxp3, transcription factor
forkhead box P3; HCC, hepatocellular carcinoma; HPA, hypothalamic−pituitary−adrenal; IL-1, interleukin-1; IL-1ra, IL-
1 receptor antagonist; iNOs, inducible nitric oxide synthase; JNK, c-Jun NH2-terminal kinase; LPS, lipopolysaccharides;
LSS, laminar shear stress; MCP-1, monocyte chemoattractant protein-1; miRNA, microRNA; NAFLD, non-alcoholic fatty
liver disease; NASH, non-alcoholic steatohepatitis; NF-κB, nuclear factor-κB; NSAIDs, non-steroidal anti-inflammatory
drugs; PGC, peroxisome proliferator-activated receptor gamma co-activator; PVNs, paraventricular neurons; RBP-4, retinol-
binding protein-4; RONS, reactive oxygen and nitrogen species; SFRP5, secreted frizzled-related protein 5; SNS, sympathetic
nervous system; sTNF-R, soluble TNF-α-receptor; TGF, transforming growth factor; Th, T helper; TLR, Toll-like receptor;
TNF, tumor necrosis factor; Tregs, regulatory T cells; WHO, World Health Organization.
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INTRODUCTION
Chronic liver disease features parenchymal damage and
repair, gradually proceeds to fibrosis and finally to cirrhosis,
accompanied by increasing hepatic impairment together with
a markedly heightened risk for HCC, a pathological process in
which cirrhosis and HCC constitute the life-threatening end state
(Liu et al., 2013). Due to the widely different etiologies, including
chronic infections with hepatotropic viruses, intoxications,
especially as a result of alcohol abuse, autoimmune diseases,
and metabolic disorder in the context of overweight or obesity,
prevention as well as treatment differ depending on the
proximate cause (Blachier et al., 2013; Giannitrapani et al.,
2013). However, irrespective of the etiology, chronic hepatic
inflammation is the response and further stimulates the progress
of the disease (Sahasrabuddhe et al., 2012; Seidler et al., 2012;
Giannitrapani et al., 2013). Consequently, the intake of NSAIDs
for example, indicated a risk reduction of both deaths from
CLD and the development of HCC, results that can be ascribed
to the ability of NSAIDs to diminish chronic inflammation
by blocking prostaglandin synthesis (Sahasrabuddhe et al.,
2012) and − specifically regarding aspirin - by down-regulating
pro-inflammatory cytokines (Imaeda et al., 2009).
Since controlling the inflammatory state within the liver
directly impacts the progression of CLD, the question arises
whether this could also be achieved naturally, supplementing
standard approaches by inherent properties that are well-
known to unleash potent anti-inflammatory effects on their
own. Physical activity is principally suitable − beside yielding
overall health-promoting benefits − to specifically generate a
quantifiable anti-inflammatory activity (e.g., Weinhold et al.,
2015) and, in contrast, the degree of physical inactivity commonly
occurring on a global scale substantially contributes to chronic
diseases and premature death (Booth et al., 2012; Lee et al., 2012).
Moreover, the discernible necessity of the body to be active might
at least in part be tied to the role that physical activity has played
in the survival of our ancestors. Capabilities like running might
have served as a tool to successfully search for food, thereby
representing a selective advantage and it was hypothesized
that endurance running might have been utilized as a hunting
method by hominids (Carrier et al., 1984) or to maximize
success in scavenging, in either case being of major importance
for the evolution of the body shape (Bramble and Lieberman,
2004) and even present-day hunter-gatherers were observed
to run after game until it dies from exhaustion (Liebenberg,
2006). Ultimately, both our environment and lifestyle have
increasingly changed within a short period of time, whereas
our genetic constitution virtually remained the same, creating a
conflict that might find its expression in chronic diseases (Eaton
et al., 1988), but might likewise be mitigated by reintegrating
activities stabilized by evolution, including physical activity, as a
permanent feature into our lives.
According to the WHO, physical inactivity is responsible
for 6% of deaths worldwide, thus appearing in the fourth
position of risk factors for mortality, and consequently, the
WHO recommends a specified amount of physical activity to
counteract the associated global burden of disease (World Health
Organization [WHO], 2010). Additionally, physical activity
or more specifically exercise has been included into practice
guidelines for the prevention and treatment of NAFLD, a medical
condition characterized by a fat mass greater than 5% related to
the total liver and the most frequent manifestation of CLD in
industrialized nations around the world (Rector and Thyfault,
2011; Neuman et al., 2015; Watanabe et al., 2015; Zhu et al., 2015;
Oliveira et al., 2016). These recommendations implicate aerobic
exercise of moderate intensity for at least 20 to 60 min on 5 days
per week in combination with resistance training performed
thrice weekly and for further benefits increasing practice beyond
250 min per week (Oliveira et al., 2016).
The goal of this review is to provide evidence for the
therapeutic applicability of exercise in advanced states of CLD,
including fibrosis, cirrhosis, and HCC, and to assess whether
exercise might be of value as adjuvant therapy in the treatment
of CLD.
THE IMPACTS OF EXERCISE ON THE
IMMUNE SYSTEM AND THE
UNDERLYING ANTI-INFLAMMATORY
MECHANISMS
It is obvious that regular endurance exercise promotes favorable
structure and metabolism adaptations in contracting organs.
However, regular sport, physical exercise, and resistance training
have also many health-promoting effects on tissues and organs
(Figure 1; Table 1). Due to the immense technological
progress within the last decades more and more people
display a predominantly sedentary way of life without the
imperative to move adequately. Additionally, dietary habits
have changed, processed foods are the standard, and often
consuming convenience foods instead of wholesome food further
compounds the situation. As a consequence, both physical
inactivity and the absence of a healthy and varied diet contribute
to a rise in overweight and obesity in the industrialized countries.
Of particular importance is the buildup of visceral fat, which
attracts pro-inflammatory immune cells, resulting in elevated
levels of pro-inflammatory adipokines − factors originating
from adipose tissue and unfolding either a pro-inflammatory
or an anti-inflammatory action − and the emergence of a
low-grade systemic inflammatory condition. This chronic low-
grade inflammation is marked by two to threefold elevated
systemic concentrations of TNF-α, IL-1, IL-6, IL-1ra, sTNFR,
and CRP (Pedersen and Febbraio, 2008). Moreover, it is
made responsible for the development of CNCDs, such as
atherosclerosis, insulin resistance, and type 2 diabetes (Ouchi
et al., 2011), neurodegenerative alterations like depression and
dementia (Leonard, 2007), and some cancers (Mathur and
Pedersen, 2008). Therefore, it is crucial to reverse this fatal
trend by bringing down obesity and low-grade inflammation
in order to prevent or ameliorate the associated morbidities.
Regular exercise offers a potent instrument to tackle chronic
inflammation (Mathur and Pedersen, 2008; Kawanishi et al.,
2013b) and its use should not be limited to the prevention of
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FIGURE 1 | Representative health-promoting effects of sports,
physical exercise, and resistance training on various organs. Numerous
reports have shown that sporting activity promotes health and functionality of
muscles, lung, heart, liver, kidney, brain, pancreas, colon, prostate, and
bones. In addition, it is reported that doing sports improves sexual function
and significantly impacts the composition of the blood. Abbreviations used
are: DAG, diacylglyerol; MCH, mean corpuscular hemoglobin; MCV, mean
corpuscular volume.
CNCDs, but it can also be useful as a treatment option (Karsten
et al., 2016), which is why exercise is meanwhile regarded as
medicine (Gleeson et al., 2011). Most of the health-promoting
effects of regular exercise are mediated by its anti-inflammatory
properties, which have been thoroughly investigated and are now
well-founded. In this chapter, we will outline the most relevant
anti-inflammatory mechanisms of exercise on the molecular
level.
Regular Exercise Reduces the Amount of
Adipose Tissue
The most noticeable outcome of exercise is the loss of body fat
over time. Although this primarily seems to affect a person’s
shape, the associated immunomodulatory changes are also
comprehensive (Figure 2). As a matter of fact, abundant fat tissue
in obesity is linked to enhanced secretion of pro-inflammatory
adipokines including TNF, leptin, IL-6 and IL-18, RBP-4,
CCL2, CXCL5, lipocalin 2, and ANGPTL2 (Ouchi et al., 2011).
Simultaneously, the production of anti-inflammatory factors, for
instance adiponectin and SFRP5, is markedly restricted (Ouchi
et al., 2011). This imbalance in favor of pro-inflammatory
adipokines finally results in the development of persistent low-
grade inflammation.
In contrast, regular physical activity increases energy
expenditure and reduces fat depots, thereby reversing the
imbalance in pro- and anti-inflammatory adipokines. As a result,
circulating levels of the anti-inflammatory factor adiponectin
rise and those of the pro-inflammatory adipokines TNF, IL-6,
RBP-4, and leptin decrease (Gleeson et al., 2011), in this way
contributing to an overall decline of systemic inflammation and
in the long run to a stabilization of this condition.
Active Skeletal Muscle Produces and
Releases IL-6
Besides cytokines like IL-8 and IL-15 contracting skeletal muscle
also produces and releases IL-6 and collectively these muscle-
derived cytokines are also referred to as myokines (Pedersen
and Febbraio, 2008). Additionally, IL-6 is also synthesized by
various other cell types, for instance, immune cells, adipocytes,
fibroblasts, endothelial cells, and different endocrine cells (Fried
et al., 1998) and it has numerous functions, but muscle-induced
secretion serves the mobilization of both hepatic glucose in
order to stabilize blood glucose levels during longer lasting
exercise (Steensberg et al., 2000; Pedersen et al., 2001) and
fatty acids through lipolysis (Pedersen et al., 2001). Typically,
levels of muscle-derived IL-6 are marginal at rest, but in
response to acute exercise they can dramatically increase
with both duration and intensity and in one study plasma
concentration of IL-6 already quadrupled after 30 minutes of
running and reached a 25-fold increase after 2.5 h at the end
of the training unit, each compared with the value measured
before the start of running (Ostrowski et al., 1998). After
finishing the marathon distance, the plasma levels of IL-6
were shown to be heightened even 100-fold (Pedersen et al.,
2001).
Since intracellular Ca2+ leads to a stimulation of IL-6
production in skeletal myocytes, whereas expression of TNF-α
- a known activator of IL-6 − is down-regulated at the same
time (Keller et al., 2006), skeletal muscle is able to synthesize IL-6
without relying on the pro-inflammatory TNF-α (Nimmo et al.,
2013). Accordingly, TNF-α is not produced by skeletal muscle in
response to exercise and IL-1β either, both characterized as classic
pro-inflammatory cytokines, and moreover IL-6 triggers the
production of IL-1ra, IL-10, and sTNFR (Petersen and Pedersen,
2005). Subsequently, these anti-inflammatory factors unfold their
specific activity: IL-1ra prevents IL-1 signaling by binding to
IL-1 receptors without stimulating a response (Pedersen and
Febbraio, 2008) and sTNFR eliminates TNF-α. Finally, IL-10 has
been shown to block the synthesis of many pro-inflammatory
cytokines, to which IL-1α, IL-1β, and TNF-α belong as well
(Petersen and Pedersen, 2005). Compared with the response
to acute exercise the production of IL-6 in adipose tissue is
triggered by TNF-α and TNF-α-induced IL-6 is considered as
pro-inflammatory (Nimmo et al., 2013).
In conclusion, IL-6 can be termed exercise factor by definition,
because it is synthesized by skeletal muscle as a result of exercise
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TABLE 1 | Health-promoting effects of physical activity/regular exercise.
Health indicator Health-promoting effects of physical activity/regular exercise Reference
Mortality and longevity All-cause mortality is reduced above all by providing cover against atherosclerosis as well as insulin resistance. Pedersen, 2006
According to one study with more than 55,000 participants being monitored for a 15-year-period, runners displayed
a 30% reduced risk of all-cause mortality and a 45% decreased risk of cardiovascular mortality as compared to
non-runners, with a gain in life expectancy of three years. Already slow running for five up to 10 min/day may
considerably lower one’s mortality risk.
Lee et al., 2014
Aging Physical activity protected against the consequences of aging for example by working against the loss of muscle
mass together with neuromuscular function.
Cvecka et al., 2015
Cardiovascular disease
and hypertension
Cardiovascular disease is marked by chronic systemic inflammation which in turn is counteracted by the
anti-inflammatory properties evolved by regular exercise: an increase in anti-inflammatory cytokines and a decrease
in the production of TNF-α, thereby protecting against cardiovascular disease and mortality.
Petersen and
Pedersen, 2006; Lavie
et al., 2015
Regular aerobic exercise brought about a reduction of blood pressure of 11/5 mm Hg on average. Börjesson et al., 2016;
Heijnen et al., 2016
Diabetes, insulin
resistance, obesity,
adiposity, and
metabolic syndrome
Physical activity reduced the risk of type 2 diabetes. The recommended amount of aerobic exercise as treatment
option for type 2 diabetes comprises at least 150 min three times a week in combination with resistance training to
build up muscle strength performed at least twice a week.
Mendes et al., 2015
Metabolic syndrome features abdominal obesity, elevated blood pressure, dyslipidemia, and a disorder of glucose
metabolism and pre-diabetes is known as one cause of metabolic syndrome. Within a period of three years the
progress from pre-diabetes to diabetes can be lowered by about 58% as a result of lifestyle modifications such as
exercise training for losing weight. Recommendations include at least 30 min of moderate training, if possible, every
day in combination with additional accommodations of the diet.
Gaesser, 2007;
Mayans, 2015
Obesity is characterized by chronic low-grade inflammation induced by metabolic substances like FFAs whose
levels are often heightened in the obese. By binding to pattern recognition receptors including TLRs and FFARs
FFAs activate inflammatory signaling pathways responsible for mediating inflammation as well as insulin resistance
in both cells displaying metabolic activity and immune cells. By means of exploitation of FFAs, down-regulation of
TLR expression and diminishing inflammatory signaling exercise is accordingly capable of restricting chronic
low-grade inflammation as well as insulin resistance.
Ringseis et al., 2015
Exercise leads to an increase in energy consumption and a decrease of (visceral) body fat, but not necessarily to
weight loss.
Sallam and Laher,
2016
Osteoporosis Exercise training can be implemented to prevent and with restrictions even to treat osteoporosis and should
comprise various elements, such as resistance training, weight lifting, also balance training, and optionally aerobic
units like walking, running, swimming as well as water aerobics. It is recommended to carry out the exercises at
least twice and up to four times a week, paying attention to one’s safety.
Moreira et al., 2014;
Giangregorio et al.,
2015
Cognitive performance Aerobic exercise, especially running, results in an enhanced release of anandamide, an endocannabinoid, which is
responsible for the rise of brain-derived neurotrophic factor (BDNF) levels and the maintenance of heightened BDNF
levels after exercise. BDNF-mediated effects on cognitive performance are achieved through stimulation of
neurogenesis and synaptic plasticity as well as through improvements concerning learning and memory resulting in
a reduced risk of cognitive impairment
Leckie et al., 2014;
Heijnen et al., 2016
Mitochondria Through generation of mitochondria and simultaneous mitophagy to remove damaged mitochondria, the overall
function of mitochondria is improved.
Romanello and Sandri,
2016
Neuroplasticity and
Neurogenesis
Physical activity promotes neuroplasticity and exercise-mediated neuroplasticity is beneficial in rehabilitation to
regain lost motor function after stroke.
Pin-Barre and Laurin,
2015
Sport enhances neurogenesis. The constant aerobic exercise, for example by using a running wheel, extended
adult hippocampal neurogenesis (AHN) in rats, particularly in those that were genetically predisposed to respond to
physical training.
Nokia et al., 2016
Cancer Exercise prevents cancer. In particular the incidence of breast, colorectal, prostate and ovarian cancers is reduced
by up to 40% combined with 50 to 60% more cancer survivors, the latter qualifying regular exercise as an important
adjuvant therapy. Due to its immunomodulatory properties exercising might be an appropriate strategy to prevent
carcinogenesis and neoplastic progression.
Newton and Galvão,
2008; Koelwyn et al.,
2015; Champ et al.,
2016; Saran et al.,
2016
Microbiome Sports favors diversity of gut bacteria that is conducive to intestinal microbiome as well as the increment of health
enhancing bacterial strains.
Cerdá et al., 2016;
Cook et al., 2016
Kidney Regular exercise ameliorates quality of life of patients with chronic kidney disease and aerobic exercise strengthens
physical fitness as well as the quality of living in dialysis patients, which is why the authors proposed to include
exercise programs into the current treatment concepts of dialysis centers.
Barcellos et al., 2015
Stress, anxiety disorder,
depression
Cortisol released in the course of aerobic exercise is subsequently transformed into the inactive cortisone as
opposed to cortisol secreted in the wake of chronic psychological stress. Due to this mechanism endurance-trained
athletes are better protected against the ramifications of sustained elevated cortisol levels including raised blood
pressure, hyperglycemia, and depression. Therefore, sports are thought to reduce the risk of stress-related illnesses
like anxiety disorder/depression.
Cerdá et al., 2016;
Heijnen et al., 2016
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FIGURE 2 | Duration- and intensity-dependent immunomodulatory changes triggered by exercise and sporting activity. Exercise increases the number
of circulating Tregs, stimulates the secretion of adrenaline and cortisol as well as the release of IL-6, leads to a reduction in fat tissue mass, and impacts the ratio of
M1-type to M2-type macrophages in fat tissue. Conversely, sporting activity reduces expression of TLRs, the intrusion of macrophages and monocytes into fat
tissue, and also the number of circulating pro-inflammatory monocytes. Altogether, these effects inhibit inflammatory reactions within the body.
and is then released into the blood circulation (Catoire and
Kersten, 2015).
Enhanced Secretion of Cortisol and
Adrenaline Owing to Exercise Induces a
Shift from a Th1 to a Th2 Immune
Response
Cortisol, a hormone of the HPA axis, is produced as a result
of stress, which can be of a physiological or of psychological
nature. A physiological stressor such as exercise feedbacks to
the hypothalamus, where CRF and to some extent AVP are
synthesized in the PVNs and subsequently released into the
hypophyseal vessels. Both factors induce the production and
exocytotic release of ACTH in the adrenal gland, which in
turn triggers the production of the glucocorticoid cortisol from
cholesterol (Stranahan et al., 2008). Furthermore, enhanced
circulating levels of IL-6 also raise plasma levels of cortisol
via ACTH secretion (Steensberg et al., 2003). In addition to
preserving blood pressure, the physiological properties of cortisol
also include the production of glucose based on proteins and
promoting lipometabolism and muscle function (Deuster et al.,
1989).
The second major pathway involved in the body’s adaptive
response to stress is the SNS, which together with the
parasympathetic nervous system and the enteric system
constitute the autonomic nervous system. Both the sympathetic
and the parasympathetic system have their origin in the
brainstem and axons of the SNS pass through the whole body,
innervating lymphoid organs as well as the adrenal gland. The
adrenal medulla predominantly secretes adrenaline, but also
noradrenaline, both at the ratio of about 4:1. Accordingly,
the primary products of the SNS are the two catecholamines
adrenaline, the principle sympathoadrenal hormone, and
noradrenaline, the major sympathetic neurotransmitter (Elenkov
et al., 2000).
SNS-induced secretion of adrenaline and noradrenaline starts
within seconds and ACTH-mediated release of cortisol within
minutes after the beginning of exercise and the circulating levels
of cortisol and adrenaline are proportional to the intensity as well
as to the duration of activity (Gleeson et al., 2011).
Glucocorticoids bind to the glucocorticoid receptor on APCs,
such as monocytes and macrophages, block the synthesis of
the pro-inflammatory IL-12 and TNF-α (Figure 3) and induce
a shift from a Th1 cell to a humoral Th2 immune response,
accompanied by a decrease in the pro-inflammatory cytokines
IFN-γ and IL-2 and an increase in the anti-inflammatory
cytokines IL-4 and IL-10, respectively, without influencing IL-10
production directly (Elenkov and Chrousos, 2002). In contrast,
catecholamines directly stimulate the synthesis of IL-10 by APCs
and also block IL-12 production by these cells, but do not
influence Th2 cells immediately. Instead, the reduction in IL-12
enables a Th2-mediated release of the anti-inflammatory acting
IL-4 and IL-10 and, additionally, triggers a decrease in the pro-
inflammatory cytokines IFN-γ and IL-2 by inhibiting Th1 cells
(Elenkov and Chrousos, 2002).
Exercise Diminishes the Number of
Circulating Pro-Inflammatory Monocytes
Monocytes derive from the bone marrow, pass into the blood, and
after a few days they end up in different tissues, supplementing
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FIGURE 3 | Systemic effects on expression of pro-inflammatory and anti-inflammatory cytokines by antigen-presenting cells. Glucocorticoids have no
impact on production of IL-10 in monocytes or macrophages, while up-regulating the expression and secretion of IL-10 and IL-4 in Th2 cells. Epinephrine or
norepinephrine induces IL-10 production by APCs, while they have no direct impact on Th2 cells. Abbreviations used are. APC, antigen-presenting cell; IFN,
interferon; IL, interleukin; Th, T helper cell; TNF-α, tumor necrosis factor-α. This figure was adapted from Elenkov and Chrousos (2002).
the local macrophage pool. Circulating monocytes display a
heterogeneous morphology, accounting for roughly 5 to 10%
of human leukocytes, and, for instance, in response to pro-
inflammatory signals they are attracted to the source and after
differentiation they reinforce the body’s defense (Gordon and
Taylor, 2005). Heterogeneity of monocytes is tied to different
cell surface markers, which allow to distinguish between two
subsets: CD14hiCD16− cells, also termed classical monocytes,
and CD14+CD16+ cells (Passlick et al., 1989), the latter is
characterized as pro-inflammatory due to their higher release of
pro-inflammatory cytokines as well as their heightened antigen-
presenting ability (Ziegler-Heitbrock, 2007) and their portion of
entire monocytes just amounts to 10% (Belge et al., 2002).
In one study, the stimulation with bacterial antigens resulted
in a 2.5 times greater expression of the TLR4 on CD14+CD16+
cells than on CD14hiCD16− monocytes (Skinner et al., 2005).
TLR4, one of 10 different TLRs in humans, belongs to the pattern-
recognition receptors and TLR4 together with CD14 recognizes
and binds LPS of gram-negative bacteria, finally leading to a rise
in the pro-inflammatory cytokines TNF-α and IL-6, which both
play a dominant role in sepsis and other inflammatory diseases
(Belge et al., 2002; Schlitt et al., 2004; Skinner et al., 2005).
Notably, there is evidence for an initial increase in
pro-inflammatory CD14+CD16+ monocytes in the blood
immediately after an exhausting bout of exercise, followed by
a substantial lowering after another hour of rest (Simpson
et al., 2009). But it might be difficult to assess whether
changes in blood cells are steady or they might occur
transiently due to mobilization of these cells and subsequent
translocation into distinct tissues (Ziegler-Heitbrock, 2007).
Regular exercise unequivocally decreases the portion of pro-
inflammatory monocytes in the blood, as it turned out
after a twelve-week exercise training of previously untrained
individuals, which was able to cut the amount of this monocyte
subpopulation by 64% and to induce a drop in TNF-α synthesis
(Timmerman et al., 2008).
Exercise Reduces the Expression of
TLRs by Monocytes/Macrophages
Toll-Like receptors are transmembrane receptors, which are
able to recognize distinctive, evolutionary conserved patterns
exposed on pathogens and to induce both innate and adaptive
immune responses (Lancaster et al., 2005). A main feature of
the TLR-induced signaling cascade is the activation of APCs,
for example monocytes, macrophages, and dendritic cells, which
produce pro-inflammatory cytokines together with chemokines
and antibacterial substances (Gleeson et al., 2006; Schon and
Weiskirchen, 2014), thereby contributing to persistent low-grade
inflammation and the formation of chronic diseases (Flynn and
McFarlin, 2006; Gleeson et al., 2006).
Results of different studies provide evidence that the
expression as well as the function of TLRs is down-regulated
in the wake of continual and exhausting exercise. For instance,
Lancaster et al. demonstrated that on monocytes the expression
of TLR1, TLR2, and TLR4 was distinctly lowered directly after
exhausting exercise and also after another two-hour period of rest
(Lancaster et al., 2005). Another investigation confirmed these
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results exclusively for the expression of TLR4 on monocytes:
Immediately after one and a half hour of cycling, TLR4 expression
declined by 32%, after 1 h at rest by 45%, and after 4 h TLR4
expression reverted to the baseline value, whereas the expression
of TLR2 did not change significantly (Oliveira and Gleeson,
2010). And directly after 45 min of running on a treadmill,
TLR2 expression decreased by 12% only on pro-inflammatory
monocytes as opposed to TLR4 expression, which diminished
by 12% after 1 h at rest independently of the subset of the cells
(Simpson et al., 2009).
The previous examples underpin the impact of acute exercise
on the cell-surface expression of TLRs, so the following study
illustrates the effect of chronic exercise on TLR expression,
what might carry weight especially in the context of chronic
inflammation. After 12 weeks of a combined endurance and
resistance training program the cell-surface expression of TLR4
on CD14+ cells was significantly lower in both younger and older
participants, whereas there was no change in TLR2 expression
(Stewart et al., 2005).
Common to the studies above is the fact that they consistently
describe the downregulation of the cell-surface expression of
TLR4, a result which becomes more important in view of the fact
that TLR4 has been shown to play a key role in the activation
of pro-inflammatory signaling induced by FFAs in obesity (Jiao
et al., 2009).
Exercise Subdues the Intrusion of
Monocytes/Macrophages Into Fat Tissue
In obesity, white adipose tissue serving as energy storage, can
be severely augmented. In addition to this increase in mass
also changes in both metabolic and endocrine functions occur,
resulting among other things in elevated levels of FFAs due
to impaired lipolysis (Weisberg et al., 2003; Jiao et al., 2009).
Furthermore, it has been demonstrated that these FFAs are
responsible for triggering the production of different monocyte
chemotactic factors in adipocytes (Nguyen et al., 2007; Jiao et al.,
2009), which in turn provoke an accumulation of macrophages in
adipose tissue (Kanda et al., 2006; Maffei et al., 2009), especially in
the visceral fat depots (Bruun et al., 2005). Finally, these clusters
of macrophages within adipose tissue add to the formation of
insulin resistance (Kanda et al., 2006).
There are at least two separate pathways whereby FFAs can
induce the expression of different monocyte chemotactic factors
in the fat cells of the mouse: First, FFAs can upregulate the
expression of MCP-1 and MCP-3 at the transcriptional level via
the JNK pathway (Jiao et al., 2009). Second, FFAs can also trigger
the expression of MCP-1, MCP-2, MCP-3, C-C motif chemokine
6 (also known as MRP-1), C-C motif chemokine 9 (also known
as MRP-2), and C-C motif chemokine 3 (also known as MIP-
1α) via NF-κB signaling in both a transcription-dependent and
independent manner (Jiao et al., 2009). Notably, only MCP-2
expression remained unaffected by selectively blocking TLR4,
suggesting that the expression of this chemokine does not rely
on TLR4 (Jiao et al., 2009). In addition, it has been documented
that FFA-mediated expression of MCP-1 also depends on JNK
signaling in murine macrophages (Nguyen et al., 2007). Beside
their function in adipose tissue there is also evidence for a similar
role of chemokines and their receptors in attracting monocytes to
atherosclerotic plaques (Gautier et al., 2009).
Although the previous reports refer to murine models, the
relevance of chemokines for the infiltration of macrophages
into adipose tissue of obese humans has also been elicited,
since gene expression of both chemokines and their receptors
was up-regulated in fat tissue of obese individuals, infiltration
of macrophages was elevated, and systemic inflammation
concomitantly intensified (Huber et al., 2008). On the other
hand the results of several studies employing mice support
the notion that exercise training can clearly prevent infiltration
of macrophages into adipose tissue, alleviate the associated
inflammation (Baynard et al., 2012; Kawanishi et al., 2012;
Kawanishi et al., 2013a,c; Linden et al., 2014), and that the
suppressed infiltration of macrophages might be related to a
decreased expression of chemokines, including MCP-1, MCP-2,
and MIP-1α in fat tissue (Kawanishi et al., 2013a).
Exercise Causes a Shift from M1-Type to
M2-Type Macrophages in Fat Tissue
Once attracted to fat tissue, macrophages undergo a phenotypical
polarization. Principally, this polarization depends on the
microenvironment and results in a change of function, making
it possible to largely separate macrophages into two basic
groups: M1 or classically activated macrophages as well as
M2 or alternatively activated macrophages, which in turn can
additionally be subdivided into M2a, M2b, and M2c, relative to
the stimuli needed for their activation (Martinez et al., 2008).
Cytokines released by Th1 cells, such as INF-γ, and also TLR
ligands, including LPS, are able to induce the M1 phenotype,
which synthesizes the pro-inflammatory cytokines TNF-α and
IL-6 as well as nitric oxide and iNOs (Ouchi et al., 2011). In
addition, M1 cells produce IL-12, which plays a central role in the
expansion of Th1 cells and the synthesis of INF-γ (Martinez et al.,
2008). However, the M2 phenotype occurs upon stimulation
with cytokines typical of Th2 cells, such as IL-4 and IL-13,
followed by the synthesis of the anti-inflammatory cytokine IL-
10, a decrease in the production of pro-inflammatory cytokines,
and an upregulation of arginase 1, mannose receptor 1, and IL-
1ra gene expression (Ouchi et al., 2011). Similar to the production
of IL-12 in the M1-type, M2 cells synthesize IL-10, thereby
stimulating the expansion of Th2 cells and the expression of IL-
4 and IL-13 by way of an interdependency between Th1/M1 and
Th2/M2 cells, respectively (Martinez et al., 2008). Interestingly,
polarization of M1 and M2 macrophages can also be reversed
in response to the respective Th2 and Th1 cytokines, which
might reflect the necessity to be able to either limit or initiate a
new immune reaction (Gratchev et al., 2006). Whereas M1 cells
display powerful microbicidal characteristics, M2 macrophages
are involved in tissue repair and also take part in resolving
inflammation (Gordon and Martinez, 2010).
By comparing obese and lean mice, it was observed that
in the latter macrophages within the adipose tissue displayed
the M2 phenotype, but with advancing adiposity the M1 cells
increased in number and finally constituted the predominant
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macrophage phenotype in the fat tissue of the animals, a
condition characterized by enhanced synthesis of TNF-α, IL-6,
and nitric oxide altogether leading to inflammation and insulin
resistance (Lumeng et al., 2007). Therefore, this study exemplifies
how diet may influence the development of an inflammatory state
and insulin resistance due to phenotype switching in adipose
tissue macrophages.
A direct influence of exercise training on the phenotype of
macrophages has been documented by a few studies in rodents.
For instance, Kawanishi et al. (2010) found that in the adipose
tissue of obese mice mRNA expression of the M1-specific marker
CD11c was lowered by chronic exercise as well as that of the
M2-specific marker CD163 was considerably heightened and,
additionally, that TLR4 expression was distinctly down-regulated
at the transcriptional level, leading to the conclusion that chronic
exercise might trigger phenotype switching from the M1- to the
M2-type and that inflammation might be prevented by means
of reduced TLR4 expression. Similar results were obtained from
obese rats in which acute exercise also resulted in the M1 to M2
shift and amelioration of insulin signaling in white adipose tissue
(Oliveira et al., 2013). Although another investigation of this
group had a slightly different focus, it nevertheless documented
that treadmill running decreased both the amount of M1-type
macrophages in visceral adipose tissue of obese mice and also
gene expression of pro-inflammatory cytokines (Kawanishi et al.,
2013a).
These examples demonstrate that the anti-inflammatory
effects of exercise might at least in part be ascribable to phenotype
switching in macrophages and this mechanism has also been
described in humans. In order to determine the influence of low-
intensity exercise on macrophage differentiation 17 sedentary
people joined an exercise program that included a walking
distance of 10,000 steps per day, three times a week for a
total of eight weeks and blood samples were analyzed before
starting the program and after 4 and 8 weeks, respectively.
Exercise led to changes in multiple values, including a rise in
leukocyte expression of the M2-specific markers CD14, CC motif
chemokine 18, also known as AMAC1, and MR, as well as
a decline in leukocyte expression of markers characteristic for
the M1 phenotype, such as IL-6, TNF-α, and MCP-1 (Yakeu
et al., 2010). Concomitantly, circulating levels of IL-10, which
is indicative of Th2 cells, were elevated and those of the Th1-
specific cytokine IL-6 dropped, collectively indicating that regular
low-intensity exercise might favor M2 macrophage polarization
(Yakeu et al., 2010).
Exercise Leads to a Higher Number of
Circulating Tregs
The impact of exercise is not restricted to effector cells
of the immune system, but there is also an influence on
immunomodulatory cells, such as Tregs, which are known for
their immunosuppressive activity, since either their lack or a
dysfunction causes systemic autoimmunity (Loser and Beissert,
2012) or aggravates inflammation and inflammation-associated
injury (Paust et al., 2011). These thymus-derived T cells express
the cell-surface markers CD4 and CD25 and, additionally, the
transcription factor Foxp3, which is why they are termed CD4+
CD25+ Foxp3+ Tregs (Sakaguchi, 2005). CD25 functions as a
receptor for IL-2 (Handzlik et al., 2013), a cytokine necessary
for the activation of Tregs by other T cells and that cannot
be produced by Tregs on their own (Turka and Walsh, 2008).
Furthermore, IL-2 is crucial for the maintenance of Tregs and
functionally amplified by TGF-β, an anti-inflammatory cytokine
that prevents apoptosis of Tregs throughout their development,
thereby also contributing to the immunosuppressive effect of this
T cell subset (Schon and Weiskirchen, 2014).
In order to gain insight into the relationship between different
T cell subsets in adipose tissue and inflammation combined
with insulin resistance in obesity, studies in both rodents and
humans were conducted. In mice, it was observed that Tregs
were markedly heightened in the abdominal adipose tissue
of lean animals, and remarkably diminished in this tissue in
their obese, insulin-resistant counterparts, suggesting that Tregs
impact tissue inflammation as well as insulin resistance (Feuerer
et al., 2009).
With regard to human adipose tissue the distribution of T cells
seems to exhibit a different pattern: Whereas the portion of Th1
and cytotoxic T cells remained stable, that of Th2 cells and Tregs
in the visceral fat of obese individuals was elevated in comparison
to those of the control group (Zeyda et al., 2011). In addition,
inflammation related to the rate of Th1 cells and cytotoxic T cells
along with Tregs, indicating that, different to the condition in
mice, inflammation of adipose tissue in the obese is not caused
by a reduction in Tregs (Zeyda et al., 2011).
Concerning the effect of exercise on the number of circulating
Tregs, experimental results in mice are in line with those in
humans. In a murine study animals were assigned to two different
groups, either performing moderate-intensity or high-intensity
exercise for a six-week period: High-intensity exercise led to an
increment of both Treg percentage and the production of the
anti-inflammatory cytokines TGF-β and IL-10, associated with a
simultaneous decline in the pro-inflammatory cytokines IL-2 and
IFN-γ, whereas moderate-intensity exercise neither affected Treg
percentage nor anti-inflammatory cytokines, but up-regulated
the expression of pro-inflammatory cytokines instead (Wang
et al., 2012). Likewise, Wilson et al. observed an augmentation
of circulating CD4+ CD25+ Tregs as well as of those specifically
expressing Foxp3 in response to exercise in young, highly-
trained swimmers (Wilson et al., 2009). In order to determine
the influence of varying training loads on both circulating
Tregs and the synthesis of IL-10 stimulated by antigens in
culture, Handzlik et al. compared blood values of participants
pertaining to four different groups, each of which corresponding
to a distinctive level of physical fitness. The data demonstrated
that an elevated number of Tregs as well as enhanced IL-10
synthesis were related to intense workouts and, further, that
there was a significant correlation between synthesis of IL-
10 and Treg proportion in total lymphocytes (Handzlik et al.,
2013).
In a more recent investigation, Weinhold et al. (2015)
addressed the question of how much circulating Tregs might
be affected by exercise and whether there exists an influence of
training loads on the number of Tregs. To that end, the rate
Frontiers in Pharmacology | www.frontiersin.org 8 August 2016 | Volume 7 | Article 283
fphar-07-00283 August 27, 2016 Time: 13:7 # 9
Schon and Weiskirchen Exercise and Liver Disease
of CD3+ CD4+ CD25high CD127low Tregs was determined in
blood samples of 245 elite athletes showing that although there
was a rise in Tregs in both male and female athletes, the number
of Tregs in females was reduced by an average of 10%, most
likely due to an influence of sex-specific hormones. Associated
with the boost of Tregs, serum levels of TGF-β likewise raised
and, conversely, blocking of TGF-β accelerated T cell growth
(Weinhold et al., 2015). These findings yet again underpinned an
intensity-dependent impact of endurance exercise on circulating
Tregs and, since the effect size was located within the scope of
physiological relevance, its association with a pronounced anti-
inflammatory status, what on the other hand might contribute to
explain the observed phenomenon of overtrained athletes being
increasingly prone to infections of the upper respiratory tract
(Weinhold et al., 2015).
Further Mechanisms
In addition to the previously described mechanisms also
longer lasting LSS generated by exercise might induce an
anti-inflammatory impact on vascular endothelial cells via
modification of gene expression patterns, including genes known
to be implicated in anti-inflammatory as well as in antioxidant
processes (Wasserman et al., 2002; Sallam and Laher, 2016).
These changes in the phenotype of endothelial cells due to
enhanced mechanical force effects might specifically promote
vascular health (Wasserman et al., 2002).
Similarly, in recent years there has been increasing evidence
for the participation of miRNAs in regulatory processes known
to be induced by exercise. Principally, miRNAs are engaged
in pro-inflammatory as well as in anti-inflammatory reactions
and circulating levels of multiple miRNAs are altered following
exercise, in part due to exercise-dependent cell damage, but most
of these miRNAs exhibit a mainly anti-inflammatory impact
(Makarova et al., 2014). In dendritic cells, for example, oxidized
low-density lipoprotein was observed to trigger inflammatory
responses during atherosclerosis, a reaction that was subdued by
miRNA-181a, resulting in a hampered release of IL-6 and TNF-
α and in an increase in the anti-inflammatory IL-10, which in
turn had been blocked by oxidized low-density lipoprotein (Wu
et al., 2012). And in vascular endothelial cells miRNA-181b was
noticed to block inflammatory signaling via NF-κB by regulating
importin α3, a factor involved in the transport of NF-κB into the
nucleus (Sun et al., 2012). In addition, miRNA-181 expression
was found to be elevated in response to acute endurance training
in murine quadriceps femoris muscles, indicating a possible
regulatory function in the adaptive processes to endurance
exercise (Safdar et al., 2009) and also rises in circulating levels
of miRNA-181b - but not of miRNA-181a − were detected with
peaks directly after an uphill course, probably as an immediate
consequence of hypoxia (Banzet et al., 2013). All of this suggests
that members of the miRNA-181 family might be important
for both contributing to an anti-inflammatory environment and
inducing adaptations in response to exercise.
Furthermore, characteristic patterns of circulating miRNAs
were described, varying from acute exhaustive to sustained
aerobic exercise, including miRNAs, like miRNA-146a, which
might also be relevant to limit inflammatory reactions (Baggish
et al., 2011). Together, these examples illustrate that miRNAs
participate in generating the anti-inflammatory effects known to
be induced by exercise and one can expect further details in the
near future.
Conclusively, a few remarks should be added. Beside the
various anti-inflammatory effects it is noteworthy that exercise
also induces multiple antioxidant effects, including modulation of
redox-sensitive pathways, such as NF-κB and PGC-1α signaling,
downregulation of pro-inflammatory signaling associated with
lowered generation of RONS, and promoting repair mechanisms
involving, for instance, heat shock proteins and telomerase
(Sallam and Laher, 2016).
Furthermore, the occurrence of some mechanisms described
above is restricted to adipose tissue in obesity, such as the
intrusion of macrophages/monocytes into fat tissue as well as
phenotype switching in macrophages, whereas others do arise
in response to exercise under normal conditions, i.e., in lean
individuals, for instance the secretion of cortisol, adrenaline and
IL-6 or the rise in the number of circulating Tregs.
Eventually, the relevance of the different anti-inflammatory
effects relies at least on the intensity and the duration of
a workload. Moreover, it is important whether exercise is
performed on a regular basis or just as a single bout. Therefore,
the effect induced by catecholamines might play a major role
in a short practice of high intensity, whereas IL-6-mediated
effects could be supposed following long lasting training and
empty glycogen stores and a rise in circulating Tregs might result
from enhanced training loads (Gleeson et al., 2011). Performing
moderate-intensity training on a regular basis might be a viable
conclusion, since this kind of training seems to be suitable for
controlling inflammation (Weinhold et al., 2015).
SIGNIFICANCE OF EXERCISE FOR THE
THERAPY OF CLD
In general, patients suffering from CLD are limited in performing
extensive physical activities. This is due to the fact that the
gradual loss in functionality impacts myriad functions of the
liver that physiologically acts as the body’s chemical factory.
As such, it is one of the major glycogen storage sites that
supply the body with readily available glucose. Liver disease is
associated with alterations in processing of glycogen synthesis
or breakdown resulting in reduced capacity to provide quick
energy during phases of exercise. Chronic ethanol consumption,
for example results in a dramatic decrease in liver glycogen
concentration that is due to direct effects of ethanol on
glycogen metabolism that is exerted at several levels, including
posttranslational modulation of enzyme activities (Van Horn
et al., 2001). Moreover, the healthy liver is a central storage
site for iron and blood, while liver disease is associated
with reduced blood oxygenation, intrahepatic angiogenesis and
other hemodynamic changes leading to portal hypertension,
again preventing extensive exercise. Particularly, this is evident
in cirrhotic, high-risk candidates for liver transplantation, in
which the oxygen consumption at peak exercise is severely
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impaired (Dharancy et al., 2008). Similarly, the disease-associated
accumulation of toxic products, such as physiological metabolites
or xenobiotics (e.g., medication), that results from limited
degradation, excretion and detoxification within the diseased
liver is a hindrance preventing extensive movements. Moreover,
the loss of the hepatic gland function (e.g., production of bile
acids) and the decreased anabolic activity in the synthesis of
proteins, fats, carbohydrates, and hormones impact the ability to
perform intense physical activity. Therefore, in the past, patients
with liver disease were often incorrectly advised to restrict their
physical activity. The view that CLD is incompatible with physical
exercise has dramatically changed during the last years.
Numerous studies in rodents and in humans focused on
the influence of exercise on NAFLD, unsurprisingly, since
this clinical syndrome occurs with increasing frequency and
meanwhile its worldwide prevalence is estimated to be in the
range of 4 to 46%, variations mainly depending on the diagnostic
procedure being used (Sherif et al., 2016), and aﬄicting more
than one out of three US citizens (Noureddin et al., 2015). The
prevalence of nonalcoholic steatohepatitis (NASH), the severe
subtype of NAFLD, which is marked by liver fat accumulation
combined with inflammation for multiple years, is considered
varying between 3 to 5% around the world (Sherif et al., 2016).
The observed rise in both obesity and the metabolic syndrome,
which in turn are closely linked to unwholesome dietary habits,
together with an absence of exercise are conducive to NAFLD
(Toplak et al., 2016), which has been identified as the leading CLD
worldwide (Paradies et al., 2014).
Several experimental studies and clinical observations have
shown that regular exercise beneficially impacts the risk of onset
and progression of CLD (Berzigotti et al., 2016). Interestingly,
under conditions that are associated with an increase of
intrahepatic lipid content such as NASH, vigorous activity that
allows reducing the overall hepatic lipid content was shown to
be more favorable than moderate activity. This was exemplarily
demonstrated in a high-fat diet-induced obese mouse model,
in which vigorous-intensity and interval treadmill running was
more effective in alleviating hepatic steatosis than moderate-
intensity and continuous treadmill running (Cho et al., 2015).
These results were also confirmed in patients with NAFLD
determined by liver biopsy: While vigorous-intensity exercise
inversely correlated with NAFLD severity, there was no such
effect visible regarding either moderate-intensity training or the
total amount of exercise (Kistler et al., 2011). In comparison with
NAFLD severity, intensity appears to be of minor importance
in terms of NAFLD prevalence. For instance, in more than
5,700 study participants increased amounts of physical activity
indicated a decrease in the prevalence of NAFLD, revealing a
dose-response relationship between physical activity and NAFLD
(Oni et al., 2015). In addition, even a reduction in the time
spent sitting together with a rise in physical activity was noticed
to result in a lower prevalence of NAFLD in a large number
of examined Koreans (Ryu et al., 2015) and also findings of a
systematic review pointed at a beneficial impact of a decreased
amount of sitting on NAFLD (Whitsett and VanWagner, 2015).
Thus, the previous outcomes imply that the therapeutical effect
might rather depend on the intensity of exercise, whereas the
actual amount of activity might more likely be sufficient for the
prevention of NAFLD.
However, also performing ordinary resistance training
exclusively composed of pushups and squats three times a week
for 12 weeks was accompanied by a gain in muscle mass, a
concomitant drop in fat mass, and improved hepatic steatosis
as well as traits of the metabolic syndrome in patients suffering
from NAFLD (Takahashi et al., 2015).
Also, clinical studies suggested that already short-term
exercise is sufficient to reduce hepatocyte apoptosis in obese
individuals with NAFLD by improving insulin sensitivity and
increasing the oxidative capacity (Fealy et al., 2012). This notion
is also confirmed in many other studies showing that active
lifestyles and caloric restriction decrease insulin resistance, body
weight, and further result in decreased histological signs of liver
injury (Gonçalves et al., 2013). Mechanistically, vigorous exercise
prevents liver disease through mitochondrial adaptations that
affect the content of cytochrome c and the activity of enzymes
that are directly linked to fatty acid oxidations (Rector et al., 2011;
Gonçalves et al., 2013). Recently, it was shown that the modifying
role on lipogenic genes is mediated via activation of the AMP-
activated protein kinase (AMPK) pathway that is central in
the regulation of cellular energy metabolism by modulating the
activity of the sterol regulatory element-binding protein family
that has been established as a group of transcription factors
regulating genes involved in cholesterol and fatty acid synthesis
(Cintra et al., 2012).
Interestingly, the exercise-induced antioxidant response in
patients who were classified as heavy drinkers was similar to that
observed in patients who did not drink heavily, suggesting that
most of the observed beneficial effects do not depend on the
health status of the liver (Georgakouli et al., 2015). A protective
role against hepatic oxidative stress induced by doxorubicin,
an antibiotic drug frequently applied to cancer treatment, was
reported by researchers who first subjected rats to daily treadmill
running for a 6-week period five times per week and subsequently
administered the drug: The aerobic training induced a significant
rise in the levels of the antioxidant enzymes superoxide dismutase
and glutathione peroxidase combined with a simultaneous
significant drop in nitric oxide and malondialdehyde, both
markers for oxidative stress (Zolfagharzadeh and Roshan, 2013).
By extension, it is also conceivable that the hepatoprotective
effect of exercise via antioxidant mechanisms might similarly
contribute to an improved tolerance of drugs by the liver and thus
reasonably support drug treatment.
Early studies regarding the effect of lifestyle modification on
NAFLD found that a combination of caloric restriction and
exercise training led to a reduction in body weight in the range of
5−10% and a significant improvement in or even a normalization
of serum ALT levels (Palmer and Schaffner, 1990; Hickman
et al., 2002). However, a major problem of these combined
approaches was that it could not be clearly determined whether
those beneficial effects had to be ascribed predominantly to
weight loss or were directly instigated by exercise training. Not
until later it has been shown that regular exercise and weight
loss independently of one another were able to normalize ALT
levels in patients with NAFLD (Suzuki et al., 2005). Subsequently,
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also other investigations confirmed marked improvements of
aminotransferase levels caused by moderate or even low intensity
exercise despite no weight loss (Sreenivasa Baba et al., 2006;
St. George et al., 2009). Although more recent findings also
substantiated these improvements of ALT levels independent of
the form of exercise (aerobic versus resistance) training and the
length of the study (Thompson et al., 2010; Fealy et al., 2012;
Khaoshbaten et al., 2013; Shamsoddini et al., 2015), others did
not (Johnson et al., 2009; Bacchi et al., 2013).
Similar to the frequently observed decrease in serum levels
of ALT, the most diagnostically conclusive biomarker for liver
injury, exercise performed on a regular basis has been reported
to lower intrahepatic lipid content (Johnson et al., 2012; Loomba
and Cortez-Pinto, 2015). A reduction of liver fat in obese
individuals solely as a result of regularly performed aerobic
exercise without any change in body weight was first documented
by Johnson et al. (2009) and the beneficial effect of aerobic
exercise training on hepatic fat in the absence of weight loss
was then confirmed in several other studies (Finucane et al.,
2010; van der Heijden et al., 2010; Sullivan et al., 2012). In
addition, also resistance training has been shown to reduce
liver fat (e.g., Zelber-Sagi et al., 2014) and there is evidence to
suggest that both forms of exercise training are equally effective in
decreasing intrahepatic fat independent of weight loss in people
aﬄicted with NAFLD (Bacchi et al., 2013; Shamsoddini et al.,
2015). Even though ALT levels approximately correlate with the
extent of liver inflammation and heightened ALT levels largely
match with the severity of NAFLD, there is only a relatively
weak correlation between ALT levels and the intensity of hepatic
fibrosis (Kim et al., 2008). Due to this, serum ALT levels are not
sufficient as an indicator of liver fibrosis on their own, but can
be combined with the serum levels of AST, another liver enzyme
and also a surrogate marker of hepatic injury, to compute the
AST/ALT ratio, which then can be applied to predict advanced
fibrosis (Wilkins et al., 2013). Apart from the AST/ALT ratio
also the AST/platelet count ratio, the FibroTest (FibroSure) or
magnetic resonance elastography are in wide use as noninvasive
biomarkers for advanced fibrosis, but liver biopsy constitutes
the norm to accurately determine the grade of inflammation as
well as the stage of fibrosis or to differentiate between simple
hepatic steatosis and NASH (Wilkins et al., 2013). Tissue samples
can serve to identify histological hepatic fibrosis for example
with the help of staining: Kawanishi et al. (2013c) employed
Sirius red and Masson trichrome to display collagen fibers
and immunohistochemical staining of α-SMA to specifically
flag activated hepatic stellate cells in murine liver tissue, since
activation of hepatic stellate cells and excessive deposition of
collagen are key events during hepatic fibrogenesis (Schon et al.,
2016). Thus, Kawanishi et al. (2013c) succeeded in demonstrating
that hepatic fibrosis was alleviated in the exercise group compared
with the control group.
Furthermore, some studies suggest that exercise can limit
hepatic inflammation and prevent the progression to states of
advanced liver damage, such as fibrosis and cirrhosis. In a
mutant form of mice, generating a hyperphagic phenotype and
fed with atherogenic food, exercise subdued inflammation in
adipose tissue and in the liver as well as the development of
NASH and of hepatic fibrosis (Haczeyni et al., 2015). Similar
results were obtained in another murine study, in which mice
were fed with a high-fat diet supplemented with high-fructose
water and performed regular exercise training on a treadmill:
Likewise hepatic injury, inflammation, and fibrosis decreased in
the animals that had undergone training compared with those of
the control group (Kawanishi et al., 2012). And reviewing the
impact of exercise in humans suffering from NAFLD, Oliveira
et al. (2016) stated that exercise is capable of alleviating liver
inflammation and oxidative stress by reducing levels of pro-
inflammatory cytokines, what may also help to prevent fibrosis,
because - beside lipid peroxidation and involvement of Fas
ligands − pro-inflammatory cytokines contribute to cumulative
liver injury.
Also, exercise has been shown to exert a beneficial influence on
accompanying symptoms of NAFLD. For instance, endothelial
dysfunction of elastic arteries - a condition that is frequently
encountered in patients with NAFLD − indicates a risk
for cardiovascular disease and constitutes an early sign of
atherosclerosis (Pugh et al., 2014). In marked contrast to
measures of conventional care, exercise training of moderate
intensity reversed endothelial dysfunction, thereby also lowering
the risk for cardiovascular disease characteristic of NAFLD, which
is why the authors proposed to prescribe exercise as an essential
part of treatment within this risk group (Pugh et al., 2014). The
positive effects on endothelial performance did occur without a
significant decline in either liver fat or visceral adipose tissue and
were thought to be generated by recurrent surges of shear stress
acting on endothelial cells (Pugh et al., 2014).
Already almost three decades ago, Ritland (1988) emphasized
that individuals suffering from CLD due to viral infection can
benefit from regular exercise, because it strengthens oxygen
consumption as well as working capacity without any signs of
impairing liver function. Even in those in an acute phase of
infection, exercise can contribute to maintain physical working
capacity, demonstrating that individuals with both acute and
CLDs can profit by physical activity (Ritland, 1988). And
the notion that exercise in general might be contraindicated
during an existing hepatic infection seems to be unfounded as
illustrated by the following rather extreme example: From 26
active participants in a 100 km ultra-marathon blood samples
were taken one week beforehand, directly after the race, and once
again 24 h upon completion and were subsequently analyzed
regarding muscle damage, liver function, and oxidative stress
parameters. There was a marked increase in all of these markers
in the 8 hepatitis B virus carriers as well as in the 18 non-infected
runners after the race, but no significant difference was detectable
between the two groups themselves (Chiu et al., 2013). Moreover,
there was also no indication of virus reactivation in carriers in
the 24-h period following the race, altogether leading to the
conclusion that neither the risk for inflammation nor for deficits
in liver function is greater in hepatitis B virus-infected runners
than in their non-infected co-runners upon participation in such
a long distance event (Chiu et al., 2013).
Less research has focused on potential benefits derived from
exercise in the terminal stage of CLD. This is particularly true for
liver cirrhosis, which is known to be associated with a decline in
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exercise capacity as well as muscle strength and an accelerated
start of anaerobic metabolism during practice (Jones et al., 2012).
Furthermore, in individuals suffering from portal hypertension,
there exist increased risks for hemorrhaging due to heightened
portal pressure in response to exercise, a fact which must be
balanced by workouts specifically adapted for the needs of these
patients (Jones et al., 2012). Up to now there are two studies
investigating the effect of exercise on individuals with cirrhosis
and both documented exercise-induced enhancements in muscle
strength as well as in exercise capacity.
In a study from 1983 five participants with liver biopsy-
confirmed cirrhosis were examined at the start of a 12-week
practice and then again twice until the end of the program.
The maximal oxygen consumption or VO2max − the amount of
oxygen, which can maximally be taken up by the body despite an
increasing physical effort (Hawkins et al., 2007), and constituting
a measure of physical fitness and endurance capacity − initially
rose by 19% in the first part and by 29% toward the end of
the period without evidence of any complications (Ritland et al.,
1983). And in two of four participants in the second study there
was an increase in the VO2peak, which characterizes the oxygen
uptake maximally attained and not necessarily identical with the
VO2max (Day et al., 2003), by 21.2 and 27.5%, respectively, and a
gain in muscle mass by 20 and 18%, whereas there was no change
in the peak oxygen uptake of the other two patients (Campillo
et al., 1990). These results admittedly hint at a positive impact of
exercise even in patients with cirrhosis, but it is also obvious that
further in-depth studies are needed to safely judge the effects in
these high-risk patients.
Some recent studies in rodents and in humans also document
a beneficial effect of exercise on the development of HCC and on
tumor growth. For instance, to determine the influence of regular
exercise on the incidence of liver cancer, genetically modified
mice were employed that spontaneously develop steatohepatitis
as well as HCC. These animals were involved in an exercise
program consisting of running on a treadmill during a 32-week
period for 1 h a day for 5 days per week. As a result of the exercise
program both the quantity and the extent of the tumors within
the examined livers were diminished, verifying that exercise is
able to restrict tumor cell proliferation (Piguet et al., 2015).
Similar results were obtained in an experimental study with
rats, that were split into four groups, one receiving only a low-
fat diet, the second a low-fat diet together with swim training,
the third a high-fat diet, and the last a high-fat diet combined
with swim training (Aguiar e Silva et al., 2012). The swim
training, which lasted for eight weeks with five training units
per week, led to a reduction in body fat and weight in the
two differently fed groups and to ameliorated cholesterol levels
in the high-fat diet group, additionally indicating that regular
exercise of that kind coupled with a reasonable, i.e., a reduced-
fat diet, might be able to abate the development of liver cancer
(Aguiar e Silva et al., 2012).
In another clinical study, including 97 patients with HCC,
low levels of adiponectin, an adipokine with predominantly anti-
inflammatory and anti-diabetic properties, were significantly
related to worse histological grades of HCC (Sumie et al., 2011)
and generally adiponectin is thought to unfold antitumor effects
as well and to assist in offering protection against HCC (Wieser
et al., 2012). In addition, adiponectin has been shown to inhibit
the progression of HCC in vitro by promoting apoptosis via
thioredoxin, an antioxidant protein (Xing et al., 2015).
Since adiponectin levels can be markedly increased after
regular exercise (Markofski et al., 2014), properly dosed exercise
should be beneficial for HCC patients. An example for the
application of exercise in respective patients is presented by
Kaibori et al. (2013), who investigated the impact of exercise on
patients with hepatectomy due to HCC. The exercise program
started one month prior to surgery, followed by a 1-week pause
immediately after the surgical operation and was then resumed
for another six months. At the end of this period fat mass as
well as whole body mass were significantly reduced associated
with a significant rise in peak oxygen consumption and anaerobic
threshold (Kaibori et al., 2013).
Finally, according to a recent study a decline in both incidence
and tumor growth by more than 60% was demonstrated in
response to regular exercise in different mouse models, also
including one model for DEN-induced liver cancer (Pedersen
et al., 2016). Just 31% of those mice that had received a DEN
injection and additionally exercised developed liver tumors as
opposed to 75% of the animals in the control group and running
also led to a significant decrease in tumor burden (Pedersen et al.,
2016). These effects were mediated by NK cells − a crucial cell
type of the innate immune system that is able to identify cancer
cells without the help of antibodies. After mobilization of NK
cells by adrenaline IL-6, which is secreted by muscle cells during
exercise, is involved in the further distribution of the immune
cells to tumors (Pedersen et al., 2016).
Interestingly, a further study reported the activation of NK
cells induced by one bout of exercise. At least for 24 h after
execution of a half marathon, both histone acetylation and the
expression of a functional marker of NK cells remained elevated,
suggesting that exercise might be helpful to reduce cancer risk as
well as recurrence rates (Zimmer et al., 2015).
Based on the previous examples, exercise might even be
of worth for advanced stages of CLD. However, from the
clinical perspective, the beneficial effects of exercise have not
been translated into positive outcomes and there is an urgent
need to implement strategies to promote a behavior change,
including the implementation of daily resistance training-
based exercise regimens to reduce liver fat, and preventing
and treatment of NAFLD (Johnson et al., 2012; Loomba and
Cortez-Pinto, 2015). Personalized exercise programs dependent
on the severity of hepatic disease might also be beneficial
to enhance blood oxygenation, improve energy metabolism,
reduce disease-associated atrophies, or to increase the patient’s
mood by stimulating the release of endorphins and modulating
neurotransmitter synthesis or activity.
CONCLUDING REMARKS
Despite constant efforts to develop effective drugs, up to
now there exist only a few agents, which are applicable to
the medication of CLD. Therefore, the conventional approach
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focuses on prevention and early diagnosis, whereas at an
advanced stage the only remaining possibility often consists
in liver transplantation. Independent of the etiology, there is
always an underlying chronic inflammation in the heart of
CLD and dampening the inflammatory state can slow down the
progression of the disease, thereby preserving and ameliorating
liver function.
Exercise has repeatedly been shown to unleash potent anti-
inflammatory effects and, conversely, a lack of physical activity is
believed to be responsible for a wide spectrum of chronic diseases.
Increased amounts of physical activity and exercise meanwhile
constitute a classic in the prevention and treatment of diseases
of the cardiovascular system, such as coronary heart disease
or heart failure (Lavie et al., 2015). Therefore, it is plausible
reasoning to make use of these benefits in the context of CLD,
too, while keeping the patients’ safety in mind. There is no doubt
that exercise can even be beneficial in an advanced stage of
liver disease and - under the guidance of qualified healthcare
professionals − can be an appropriate adjuvant therapy. In
response to exercise, various endogenous agents are produced,
which unfold a quantifiable pharmacological activity, thereby
contributing to recovery. Since exercise has been shown to be
effective in both prevention and therapy of certain chronic
diseases, consequently the notion of exercise as medicine was
coined (Gleeson et al., 2011). But it is also necessary to determine
the optimal amount and intensity of exercise and to identify the
most suitable workout to maximize its value. In order to obtain
this knowledge, further studies are essential. As long as these
questions are unanswered, it will yet be better to be physically
active for at least 5 to 10 min every day than to stay inactive, since
such small amounts are already connected with a clear drop in the
risks of all-cause and cardiovascular mortality (Lee et al., 2014).
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